Otezla Now Approved for Plaque Psoriasis Across All Severities
The approval was based on data from the phase 3 ADVANCE trial.
The approval was based on data from the phase 3 ADVANCE trial.
A 29-year-old man presents to the dermatology clinic for evaluation of a rash on his body that began 2 weeks ago. Can you make the diagnosis?
Previously unrecognized pathogenic mechanisms involving ocular contact dermatitis has driven new approaches to control the inflammatory process.
Clinician competence in treating patients of various racial and ethnic backgrounds and the critical need for greater inclusion of diverse populations in trials investigating the pathophysiology and treatment of AD are underscored.
A team of investigators sought to assess the relationship between thiazides, thiazide-like diuretics, or calcium channel blockers and the development of basal cell carcinoma, squamous cell carcinoma, or cutaneous malignant melanoma.
Expert on vitiligo John E. Harris, MD, associate professor of dermatology at University of Massachusetts Medical School (UMMS) in Worcester, spoke with us about the skin disorder.
Two patients present with nodules on the feet and hands.
Use of permanent hair dye is not associated with the risk for most cancers or cancer mortality.
The COVID-19 pandemic has illuminated an ongoing concern about antimicrobial resistance in dermatology and requires a recommitment from clinicians to follow guidelines that promote good stewardship.